Literature DB >> 10995391

p53-independent functions of the p19(ARF) tumor suppressor.

J D Weber1, J R Jeffers, J E Rehg, D H Randle, G Lozano, M F Roussel, C J Sherr, G P Zambetti.   

Abstract

The p19(ARF) tumor suppressor antagonizes Mdm2 to induce p53-dependent cell cycle arrest. Individual TKO (triple knock out) mice nullizygous for ARF, p53, and Mdm2 develop multiple tumors at a frequency greater than those observed in animals lacking both p53 and Mdm2 or p53 alone, demonstrating that p19(ARF) can act independently of the Mdm2-p53 axis in tumor surveillance. Reintroduction of ARF into TKO mouse embryo fibroblasts (MEFs), but not into those lacking both p53 and ARF, arrested the cell division cycle in the G1 phase. Inhibition of the retinoblastoma protein had no effect on the ability of ARF to arrest TKO MEFs. Thus, in the absence of Mdm2, p19(ARF) interacts with other targets to inhibit cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995391      PMCID: PMC316930          DOI: 10.1101/gad.827300

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  49 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.

Authors:  A Carnero; J D Hudson; C M Price; D H Beach
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

3.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

Review 4.  The p53 gene family.

Authors:  W G Kaelin
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

5.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

6.  Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

Authors:  J J Jacobs; B Scheijen; J W Voncken; K Kieboom; A Berns; M van Lohuizen
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

7.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

8.  Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

Authors:  J Roth; M Dobbelstein; D A Freedman; T Shenk; A J Levine
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

9.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

10.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

View more
  126 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Authors:  Anthony J Saporita; Hsiang-Chun Chang; Crystal L Winkeler; Anthony J Apicelli; Raleigh D Kladney; Jianbo Wang; R Reid Townsend; Loren S Michel; Jason D Weber
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

3.  Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.

Authors:  Abhishek Datta; Alo Nag; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.

Authors:  Md Kamrul Hasan; Tomoko Yaguchi; Yasumasu Minoda; Takashi Hirano; Kazunari Taira; Renu Wadhwa; Sunil C Kaul
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

5.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Antiviral action of the tumor suppressor ARF.

Authors:  María A García; Manuel Collado; César Muñoz-Fontela; Ander Matheu; Laura Marcos-Villar; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

7.  Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype.

Authors:  Philip J Mitchell; Elena Perez-Nadales; Denise S Malcolm; Alison C Lloyd
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Authors:  Suzanne N Brady; Yue Yu; Leonard B Maggi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.

Authors:  C M Eischen; M F Roussel; S J Korsmeyer; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.